National Heart, Lung, and Blood Institute (NHLBI): Diabetes Mellitus, Type 2 trials

The registry lists 14 Diabetes Mellitus, Type 2 studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 0 are open to participants now and 1 have results posted.

Phase 2 1Phase 3 1No phase 12(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Action to Control Cardiovascular Risk in Diabetes (ACCORD)CompletedNCT00000620Phase 3Results posted
• Rosiglitazone to Reverse Metabolic Defects in DiabetesCompletedNCT00094796Phase 2
• Mechanisms of Pro-Thrombosis in Diabetes Mellitus -- Ancillary to BARI 2DCompletedNCT00041405
• Epidemiology of Cardiovascular Disease in DiabetesCompletedNCT00037297
• VA HDL Intervention Trial (VA-HIT) Ancillary Study Data AnalysisCompletedNCT00035711
• Sleep Apnea in Look AHEAD Participants - Ancillary to Look AHEADCompletedNCT00031239
• Heavy Metals, Obesity and Cardiovascular Risk - Ancillary to Look AHEADCompletedNCT00031213
• MRI Derived Organ & Tissue Mass Changes With Weight Loss - Ancillary to Look AHEADCompletedNCT00031200
• Prenatal Nutrition and Adult DiseaseCompletedNCT00024583
• Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic ControlCompletedNCT00021944
• Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNTCompletedNCT00021918
• Multi-Ethnic Study of Atherosclerosis (MESA)Active, not recruitingNCT00005487
• Genetics of Atherosclerosis in Mexican AmericansCompletedNCT00005462
• Prospective Study of Diabetes-related Vascular Disease in Oklahoma IndiansCompletedNCT00005193